Rossleigh M A, Lovegrove F T, Reynolds P M, Byrne M J, Whitney B P
Aust N Z J Med. 1984 Feb;14(1):19-22. doi: 10.1111/j.1445-5994.1984.tb03578.x.
Serial bone scans, x-rays and records of bone pain were reviewed in order to determine the relative contributions of these parameters in the assessment of response of bone metastases to treatment. Twenty-seven patients with abnormal bone scans due to metastatic breast cancer were studied. Ten of the patients showed an early temporary flare on bone scan including five with apparent new lesions. Confirmation that such new lesions did not denote progressive disease was provided by subsequent improvement in symptoms and reduction in intensity and number of lesions on a follow-up bone scan, without any change in systemic therapy. Serial x-rays were found to be unreliable as a sole method for assessing response to therapy or disease progression, as in only seven of the 27 patients could a definitive radiological assessment of response be made. In only one patient did x-rays improve the accuracy of the scan by distinguishing between a healing flare and progressive disease. In contrast, this distinction was made in seven of the 10 patients on the basis of improvement in bone pain at the time of the flare. The other 3 patients had no bone pain prior to therapy or at the time of the flare. Tentative response criteria incorporating bone scan, x-ray and symptoms are suggested. The criteria incorporate recognition of the fact that new lesions appearing on a bone scan within six months of initiation of therapy may comprise part of a healing flare response.
回顾了系列骨扫描、X线检查及骨痛记录,以确定这些参数在评估骨转移瘤治疗反应中的相对作用。研究了27例因转移性乳腺癌导致骨扫描异常的患者。其中10例患者在骨扫描上出现早期暂时的“闪烁”现象,包括5例有明显新病灶者。后续症状改善、随访骨扫描时病灶强度及数量减少,且全身治疗无变化,证实这些新病灶并不意味着疾病进展。发现系列X线检查作为评估治疗反应或疾病进展的唯一方法并不可靠,因为27例患者中只有7例能做出明确的放射学反应评估。只有1例患者的X线检查通过区分愈合性“闪烁”和疾病进展提高了扫描的准确性。相比之下,10例患者中有7例根据“闪烁”时骨痛的改善做出了这种区分。另外3例患者在治疗前或“闪烁”时无骨痛。提出了纳入骨扫描、X线检查和症状的初步反应标准。该标准纳入了这样一个事实,即治疗开始后6个月内骨扫描上出现的新病灶可能是愈合性“闪烁”反应的一部分。